Goldberg A R, Wong T W
Adv Enzyme Regul. 1984;22:289-308. doi: 10.1016/0065-2571(84)90019-0.
We have demonstrated the usefulness of several angiotensin analogs as substrates for a number of tyrosyl protein kinases of viral or cellular origin. Results of initial rate studies with pp60src at varying substrate concentrations indicated that the mechanism was sequential; Michaelis constants for ATP and peptide were 7 microM and 0.24 microM respectively and Vmax was 1.0 nmol/min/mg. The end-product ADP and the ATP analog, AMP-PNP, were competitive inhibitors at varying ATP concentrations and noncompetitive inhibitors at varying peptide concentrations. A dead-end analog of angiotensin II, [delta Phe4]-angiotensin II, was a noncompetitive inhibitor at varying ATP concentrations but induced substrate inhibition at varying peptide concentrations. The kinetic data allowed us to conclude that the reaction proceeded via an Ordered Bi Bi mechanism with ATP as the first binding substrate. The available evidence allowed us to conclude that while pp60src contained essential histidine and lysine residues in its active site, the kinase reaction does not involve a phosphoryl enzyme intermediate. Phosphorylation of the angiotensin peptides in vitro also has allowed us to demonstrate the presence of at least two tyrosyl protein kinases in the cytoplasm of normal rat liver cells. These kinases appear to be novel in that they are present in normal cells and are not stimulated by growth factors. Also, results of preliminary experiments indicate that these kinases are not immunologically related to the transforming gene products of Rous and Fujinami sarcoma viruses (unpublished observations). The identification of these new kinases represents another application of the angiotensin peptides as substrates for tyrosyl kinases (13). The results obtained do not exclude the possibility that there exist in rat liver other tyrosyl kinases that do not phosphorylate these particular peptide substrates. No attempt has been made to characterize tyrosyl kinases associated with the plasma membrane fraction. Although they represent only a small fraction of the total activity of liver cells, the plasma membrane kinases have a relatively high specific activity. These kinases may be identical with growth factor receptor kinases previously identified in liver cell membranes (5). The most abundant tyrosyl kinase in rat liver cytoplasm has a molecular weight of 75,000 daltons and was found in cytosol and microsomal salt-wash fraction. The observation that the purified 75 Kd enzyme phosphorylates a 75 Kd protein on tyrosine residues suggests that the enzyme may possess autophosphorylating activity.(ABSTRACT TRUNCATED AT 400 WORDS)
我们已经证明了几种血管紧张素类似物可作为多种病毒或细胞来源的酪氨酰蛋白激酶的底物。在不同底物浓度下对pp60src进行的初速率研究结果表明,其机制是顺序性的;ATP和肽的米氏常数分别为7微摩尔和0.24微摩尔,Vmax为1.0纳摩尔/分钟/毫克。终产物ADP和ATP类似物AMP-PNP在不同ATP浓度下是竞争性抑制剂,在不同肽浓度下是非竞争性抑制剂。血管紧张素II的一种终产物类似物[δPhe4]-血管紧张素II在不同ATP浓度下是非竞争性抑制剂,但在不同肽浓度下会引起底物抑制。动力学数据使我们得出结论,该反应通过有序的双底物双产物机制进行,ATP是第一个结合底物。现有证据使我们得出结论,虽然pp60src在其活性位点含有必需的组氨酸和赖氨酸残基,但激酶反应不涉及磷酸化酶中间体。血管紧张素肽的体外磷酸化也使我们能够证明正常大鼠肝细胞细胞质中至少存在两种酪氨酰蛋白激酶。这些激酶似乎是新颖的,因为它们存在于正常细胞中且不受生长因子刺激。此外,初步实验结果表明,这些激酶与劳氏肉瘤病毒和藤浪肉瘤病毒的转化基因产物没有免疫相关性(未发表的观察结果)。这些新激酶的鉴定代表了血管紧张素肽作为酪氨酰激酶底物的另一种应用(13)。所获得的结果并不排除大鼠肝脏中存在其他不使这些特定肽底物磷酸化的酪氨酰激酶的可能性。尚未尝试对与质膜部分相关的酪氨酰激酶进行表征。尽管它们仅占肝细胞总活性的一小部分,但质膜激酶具有相对较高的比活性。这些激酶可能与先前在肝细胞膜中鉴定出的生长因子受体激酶相同(5)。大鼠肝脏细胞质中最丰富的酪氨酰激酶分子量为75,000道尔顿,存在于胞质溶胶和微粒体盐洗部分。纯化的75 Kd酶在酪氨酸残基上使一种75 Kd蛋白磷酸化的观察结果表明该酶可能具有自磷酸化活性。(摘要截短至400字)